SurgLine enters pact with MedNPV to supply low cost spinal implants

SurgLine International, Inc., a development stage company that owns unique patent pending solar and photovoltaic related technology, has signed an agreement with MedNPV, LLC (MedNPV), a well-established management company and surgical group operator with business throughout the state of California. The agreement between the parties will permit SurgLine to supply its’ low cost spinal orthopaedic implants.  Based upon MedNPV’s current business they are forecasting up to 40 monthly surgeries.
“We are pleased to announce that we will be working with a MedNPV to replace a competitor’s higher cost product offering with our lower priced offering for spinal orthopaedic implants,” said Thomas Toland, CEO of SGLN and SurgLine, Inc.  “Together, we are focused on delivering more value for the end users with  excellent quality products with lower costs.  Based on the current mix of surgeries, the three year agreement is expected to generate $100,000 in monthly sales. This agreement underscores that we are progressing in our business plan and making significant strides in our market penetration.”
“As healthcare costs become increasingly more cost prohibitive for insurance companies and the self-insured employers, our client was looking to provide a solution for prospective surgical cost containment,” said senior managing director of MedNPV, I. Shone Clark.
SurgLine sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centres, surgical hospital, self-insured employers and insurance companies.
MedNPV provides national healthcare finance solutions by converting lien-secured receivables to cash in the Workers’ Compensation industry. This process is achieved by purchasing the accounts receivables at a significant discount of the providers usual and customary reimbursement rates.